PMC:7441788 / 37248-37436 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T148","span":{"begin":78,"end":87},"obj":"Disease"},{"id":"T149","span":{"begin":104,"end":112},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithrom"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T135","span":{"begin":104,"end":112},"obj":"Species"}],"attributes":[{"id":"A135","pred":"ncbi_taxonomy_id","subj":"T135","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithrom"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1346","span":{"begin":31,"end":39},"obj":"Species"},{"id":"1371","span":{"begin":53,"end":56},"obj":"Chemical"},{"id":"1411","span":{"begin":78,"end":87},"obj":"Disease"},{"id":"1412","span":{"begin":104,"end":112},"obj":"Disease"},{"id":"1413","span":{"begin":134,"end":150},"obj":"Disease"}],"attributes":[{"id":"A1346","pred":"pubann:denotes","subj":"1346","obj":"Tax:9606"},{"id":"A1371","pred":"pubann:denotes","subj":"1371","obj":"MESH:D006886"},{"id":"A1411","pred":"pubann:denotes","subj":"1411","obj":"MESH:D011014"},{"id":"A1412","pred":"pubann:denotes","subj":"1412","obj":"MESH:C000657245"},{"id":"A1413","pred":"pubann:denotes","subj":"1413","obj":"MESH:D008133"}],"text":"recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithrom"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T141","span":{"begin":78,"end":87},"obj":"Disease"},{"id":"T142","span":{"begin":104,"end":112},"obj":"Disease"}],"attributes":[{"id":"A141","pred":"mondo_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A142","pred":"mondo_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithrom"}

{"project":"LitCovid-sample-PD-HP","denotations":[{"id":"T36","span":{"begin":78,"end":87},"obj":"Phenotype"}],"attributes":[{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithrom"}

{"project":"LitCovid-PubTator","denotations":[{"id":"1346","span":{"begin":31,"end":39},"obj":"Species"},{"id":"1371","span":{"begin":53,"end":56},"obj":"Chemical"},{"id":"1411","span":{"begin":78,"end":87},"obj":"Disease"},{"id":"1412","span":{"begin":104,"end":112},"obj":"Disease"},{"id":"1413","span":{"begin":134,"end":150},"obj":"Disease"}],"attributes":[{"id":"A1346","pred":"tao:has_database_id","subj":"1346","obj":"Tax:9606"},{"id":"A1371","pred":"tao:has_database_id","subj":"1371","obj":"MESH:D006886"},{"id":"A1411","pred":"tao:has_database_id","subj":"1411","obj":"MESH:D011014"},{"id":"A1412","pred":"tao:has_database_id","subj":"1412","obj":"MESH:C000657245"},{"id":"A1413","pred":"tao:has_database_id","subj":"1413","obj":"MESH:D008133"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithrom"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T37","span":{"begin":78,"end":87},"obj":"Phenotype"}],"attributes":[{"id":"A37","pred":"hp_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"recent observation showed that patients who received HCQ for the treatment of pneumonia associated with COVID-19 were at high risk of QTc prolongation (19%), and concurrent use of azithrom"}